Klingenstein Fields & CO LP Abb Vie Inc. Transaction History

Klingenstein Fields & CO LP

$2.48 Billion
Q3 2024

A detailed history of Klingenstein Fields & CO LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 11,850 shares of ABBV stock, worth $1.99 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,850

Previous 12,014 1.37%

Holding current value

$1.99 Million

Previous $2.06 Million 13.59%

% of portfolio

0.09%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $26,869 - $32,690	-164 Reduced 1.37%	11,850 $2.34 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $45,972 - $53,685	-297 Reduced 2.41%	12,014 $2.06 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $68,402 - $77,938	-428 Reduced 3.36%	12,311 $2.24 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $337,945 - $380,606	-2,456 Reduced 16.16%	12,739 $1.97 Million
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $16,297 - $18,867	122 Added 0.81%	15,195 $2.26 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $11,263 - $14,016	-85 Reduced 0.56%	15,073 $2.03 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $43,238 - $49,795	-299 Reduced 1.93%	15,158 $2.42 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $62,516 - $74,973	452 Added 3.01%	15,457 $2.5 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $53,818 - $61,725	401 Added 2.75%	15,005 $2.01 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $10,183 - $12,947	-74 Reduced 0.5%	14,604 $2.24 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $30,617 - $38,740	285 Added 1.98%	14,678 $1.99 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $42,134 - $47,828	-396 Reduced 2.68%	14,393 $1.55 Million
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $59,443 - $66,223	-565 Reduced 3.68%	14,789 $1.67 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $1,739 - $1,914	-17 Reduced 0.11%	15,354 $1.66 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $8,290 - $11,193	-103 Reduced 0.67%	15,371 $1.65 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $3,694 - $4,335	43 Added 0.28%	15,474 $1.36 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $14,233 - $19,046	194 Added 1.27%	15,431 $1.52 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $132,225 - $200,469	-2,050 Reduced 11.86%	15,237 $1.16 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $45,441 - $56,857	-630 Reduced 3.52%	17,287 $1.53 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $26,577 - $31,953	422 Added 2.41%	17,917 $1.36 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $65 - $83	-1 Reduced 0.01%	17,495 $1.27 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $28,541 - $33,592	-370 Reduced 2.07%	17,496 $1.41 Million
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $8,952 - $11,041	-115 Reduced 0.64%	17,866 $1.65 Million
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $30,051 - $33,407	338 Added 1.92%	17,981 $1.7 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $16,429 - $19,440	183 Added 1.05%	17,643 $1.64 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $9,661 - $12,937	-105 Reduced 0.6%	17,460 $1.65 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $33,585 - $36,828	375 Added 2.18%	17,565 $1.7 Million
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $1.2 Million - $1.53 Million	17,190	17,190 $1.53 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Abb Vie Inc. Transaction History